|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.50 GBX | -4.92% |
|
-6.45% | -12.12% |
| 05-26 | Pathos deal win; ProBiotix eyes "market opportunity" | AN |
| 05-26 | Velocity Composites says there has been no short-term impact from Iran conflict | RE |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| - | 0.345 | +137.93% | 2 | ||||||
| 341.75 | +8.01% | 22 | |||||||
| 305.13 | +12.83% | 20 | |||||||
| 1,524.5 | +19.35% | 20 | |||||||
| 386.1 | +14.85% | 20 | |||||||
| 788.17 | +3.35% | 6 | |||||||
| 386.1 | +18.73% | 20 | |||||||
| - | - | - | - | - | |||||
| 35.61 | +31.98% | 14 | |||||||
| - | - | - | - | - | |||||
| - | - | - | - | - | |||||
| - | 21.28 | +12.06% | 1 | ||||||
| 164 | -0.76% | 5 | |||||||
| - | - | 23 | +30.09% | 1 | |||||
| 43.7 | +23.13% | 5 | |||||||
| - | - | 29.23 | +25.88% | 1 | |||||
| Average | 311.45 | +25.96% | 11 | ||||||
| Weighted average by Cap. | 544.94 | +12.56% | 19 |
- Stock Market
- Stocks
- VEL Stock
- Sector Velocity Composites plc
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
















